跳至主要内容
临床试验/NCT02014298
NCT02014298已完成不适用

LONG-TERM AND CONTINUED IMPROVEMENT OF MATURE BURN SCARS IN RESPONSE TO NONABLATIVE FRACTIONAL LASER - A RANDOMIZED CONTROLLED TRIAL WITH HISTOLOGICAL EVALUATION

Bispebjerg Hospital2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Change in overall Scar-appearance

研究概览

简要总结

BACKGROUND: Increasing evidence appears for non-ablative fractional laser (NAFL) to remodel mature burn scars.

OBJECTIVES: To investigate long-term clinical and histological appearance of mature burn scars after NAFL-treatment.

HYPOTHESIS: That NAFL can modulate mature burn scars with subsequently improved cosmetic and functional appearance.

METHODS: Study patients with burn scars at trunk or extremities. Side-by-side test areas are randomized to three monthly 1,540 nm NAFL-treatments or control, followed by blinded evaluations at 1, 3, and 6 months using mPOSAS (modified Patient and Observer Scar Assessment Scale; 1 = normal skin, 10 = worst imaginable scar).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • legally competent adults aged 18-60 years
  • Fitzpatrick skin type I-III
  • burn scar 1 year or older
  • total scar area allowing selection of two similar side-by-side test areas of minimum 1.5 × 3 cm for study purpose

排除标准

  • pregnancy or lactation
  • wounds or infections in study area
  • tendency to form hypertrophic scars or keloids
  • oral retinoids, anti-inflammatory or immunosuppressive drugs within the last six months
  • current anticoagulants
  • previous treatments in test area with laser, Intense Pulsed Light, dermabrasion, chemical peel or filler.

结局指标

主要结局

Change in overall Scar-appearance

时间窗: 1,3 and 6 months follow-up

Primary endpoint is change in overall scar-appearance assessed by a slightly modified Patient and Observer Scar Assessment Scale (evaluation of study area omitted since this is fixed as part of study procedure). Scale: 1= normal skin; 10= worst imaginable scar.

次要结局

  • specific clinical and histological scar appearance(1, 3, and 6 months follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elisabeth Taudorf

MD

Bispebjerg Hospital

研究点 (2)

Loading locations...

相似试验